Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects.

Translational and clinical pharmacology(2023)

引用 0|浏览0
暂无评分
摘要
ClinicalTrials.gov Identifier: NCT04334213.
更多
查看译文
关键词
Diabetes Mellitus,Drug Interactions,Pharmacokinetics,Thiazolidinediones
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要